Comparison of Efficacy of Sertaconazole Nitrate Cream 2 Percent vs Clotrimazole 1 Percent for the Treatment of Tinea Pedis
DOI:
https://doi.org/10.70749/ijbr.v3i7.1855Keywords:
Tinea Pedis, Efficacy, Sertaconazole Nitrate, ClotrimazoleAbstract
Introduction: Tinea pedis is commonly referred to as athlete's foot. Tinea pedis is the consequence of superficial fungal infections on the foot skin brought on by dermatophytes. Among the most prevalent fungal infections of the foot worldwide, its frequency is rapidly rising. Topical imidazoles are effective ways for curing tinea pedis since they work well and have minimal side effects. In the study efficacy of topical Sertaconazole was compared with Clotrimazole on the lesions of Tinea pedis. Objective: To compare the Efficacy of Sertaconazole Nitrate Cream 2% Vs. Clotrimazole 1% for the Treatment of Tinea Pedis. Methodology: This randomized controlled trial study was carried out on OPD patients in the Department of Dermatology, Jinnah Postgraduate Medical Center (JPMC) Karachi, Pakistan. Patients of Tinea Pedis who met the selection criteria were enrolled in the study. Participants were randomly allocated in into two groups; patients of Group-A had used topical Sertaconazole 2% and patients in Group-B had used Clotrimazole 1%. Over four weeks, both creams were used topically twice daily. The patients were assessed at the final follow-up using all clinical investigations and a microscopic analysis. The effectiveness of the therapies was defined as a reduction in the overall composite score of at least two points with a negative KOH test following four weeks of therapy and the reporting of no adverse effects. All of the patients' adverse drugs events were observed. Results: Mean age was 30.39 years, with an SD of 8.56 years. Males represented 48% of patients in the Clotrimazole group and 50% of patients in the Sertaconazole group. Post-treatment signs and symptoms score showed, individuals received Sertaconazole, signs and symptoms reduced significantly. The study finding showed that the efficacy rate of Sertaconazole was higher than the patients in the clotrimazole group (86% vs. 66%; P-value <0.05). Conclusions: Topical sertaconazole 2% cream was found to be highly efficacious and superior to clotrimazole 1% cream in improvement of clinical parameters of tinea pedis.
Downloads
References
1. Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, et al. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018;18(1):6.
https://doi.org/10.1186/s12895-018-0073-1
2. Nigam PK, Syed HA, Saleh D. Tinea Pedis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.
https://doi.org/10.1080/15424065.2024.2389325
3. Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea pedis: an updated review. Drugs Context. 2023;12.
https://doi.org/10.7573/dic.2023-5-1
4. Chanyachailert P, Leeyaphan C, Bunyaratavej S. Cutaneous fungal infections caused by dermatophytes and non-dermatophytes: an Updated Comprehensive Review of Epidemiology, Clinical presentations, and diagnostic testing. Journal of Fungi. 2023;9(6):669.
https://doi.org/10.3390/jof9060669
5. Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374-88.
https://doi.org/10.3109/1040841x.2013.856853
6. Henderson A, Rasul T, Morgan O, Rafie C, Anderson J, Mathew M, et al. Tinea pedis epidemiology and importance from the lens of homelessness and low-resource settings. Arch Clin Biomed Res. 2024;8:45-53.
https://doi.org/10.21203/rs.3.rs-1447758/v1
7. Nowicka D, Nawrot U. Tinea pedis—An embarrassing problem for health and beauty—A narrative review. Mycoses. 2021;64(10):1140-50.
https://doi.org/10.1111/myc.13340
8. Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77-86.
9. Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. CUTIS-NEW YORK-. 2006;78(4):268.
10. Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702-10.
11. Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, De R. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study. Indian J Pharmacol. 2016;48(6):659-64.
https://doi.org/10.4103/0253-7613.194850
12. Shivamurthy RP, Reddy SG, Kallappa R, Somashekar SA, Patil D, Patil UN. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study. J Clin Diagn Res. 2014;8(9):Hc09-12.
https://doi.org/10.7860/jcdr/2014/10210.4866
13. Giri VP, Gupta SK, Giri OP, Matreja PS. Sertaconazole nitrate 2% cream for the treatment of tinea pedis. Nat J Lab Med. 2016;5:1-5.
14. Abdalla, A., El-Sawy, H., Ramadan, A. Emergence of Advanced Antifungal-Delivery Approaches for the Treatment of Tinea Pedis. ERU Research Journal, 2024; 3(2): 1058-1089.
https://doi.org/10.21608/erurj.2024.227252.1064.
15. Lakhani SJ, Joshi DB, Kumbhani KR, Haldia RB. Prospective study on comparison of efficacy of topical anti-fungal agents: Clotrimazole 1% and sertaconazole 2% in treatment of tinea cruris. Int J Res Dermatol. 2020 Jan;6:43-7.
https://doi.org/10.18203/issn.2455-4529.intjresdermatol20195672
16. Khondker L. Efficacy and safety of sertaconazole in the treatment of dermatophytoses. Journal of Pakistan Association of Dermatologists. 2021 Mar 4;31(1):42-50.
17. Jerajani H, Janaki C, Kumar S, Phiske M. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study. Indian J Dermatol. 2013;58:34–8.
https://doi.org/10.4103/0019-5154.105284
18. Romaguera C, Herrero E, Márquez M, Torres J, Ortiz JA. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses. Arzneimittelforschung. 1992;42(5A):754-6.
https://doi.org/10.2165/00128413-199208410-00029
19. Dakhale GN, Gupta AV, Mukhi JI, Kalikar MV. Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study. Perspectives in Clinical Research. 2021 Oct 1;12(4):223-8.
https://doi.org/10.4103/picr.picr_24_19
20. Ghahartars M, Hosseini H, Khedri M, Sadati MS. Comparison of the Efficacies of Topical Liposomal Amphotericin B and Topical Clotrimazole in the Treatment of Pityriasis Versicolor. Dermatol Pract Concept. 2024 Jan 1;14(1):e2024083. PMID: 38364431; PMCID: PMC10869028.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
